16-81377486-C-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_022041.4(GAN):​c.1684C>G​(p.Pro562Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00473 in 1,614,106 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P562P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 25 hom. )

Consequence

GAN
NM_022041.4 missense

Scores

2
2
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:2B:11

Conservation

PhyloP100: 6.08

Publications

6 publications found
Variant links:
Genes affected
GAN (HGNC:4137): (gigaxonin) This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008]
GAN Gene-Disease associations (from GenCC):
  • giant axonal neuropathy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 11 curated pathogenic missense variants (we use a threshold of 10). The gene has 3 curated benign missense variants. Trascript score misZ: -2.0288 (below the threshold of 3.09). GenCC associations: The gene is linked to giant axonal neuropathy 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.010434002).
BP6
Variant 16-81377486-C-G is Benign according to our data. Variant chr16-81377486-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 374635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00378 (576/152350) while in subpopulation NFE AF = 0.00557 (379/68034). AF 95% confidence interval is 0.00511. There are 0 homozygotes in GnomAd4. There are 256 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 25 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GANNM_022041.4 linkc.1684C>G p.Pro562Ala missense_variant Exon 11 of 11 ENST00000648994.2 NP_071324.1 Q9H2C0A0A0S2Z4W2B3KTC3
GANNM_001377486.1 linkc.1045C>G p.Pro349Ala missense_variant Exon 10 of 10 NP_001364415.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GANENST00000648994.2 linkc.1684C>G p.Pro562Ala missense_variant Exon 11 of 11 NM_022041.4 ENSP00000497351.1 Q9H2C0

Frequencies

GnomAD3 genomes
AF:
0.00378
AC:
576
AN:
152232
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00227
Gnomad FIN
AF:
0.00828
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00557
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00482
AC:
1212
AN:
251302
AF XY:
0.00523
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00516
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0101
Gnomad NFE exome
AF:
0.00620
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00483
AC:
7065
AN:
1461756
Hom.:
25
Cov.:
31
AF XY:
0.00485
AC XY:
3525
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33478
American (AMR)
AF:
0.00224
AC:
100
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00520
AC:
136
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00383
AC:
330
AN:
86258
European-Finnish (FIN)
AF:
0.0103
AC:
550
AN:
53418
Middle Eastern (MID)
AF:
0.00624
AC:
36
AN:
5768
European-Non Finnish (NFE)
AF:
0.00511
AC:
5687
AN:
1111882
Other (OTH)
AF:
0.00339
AC:
205
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
426
851
1277
1702
2128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00378
AC:
576
AN:
152350
Hom.:
0
Cov.:
32
AF XY:
0.00344
AC XY:
256
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000794
AC:
33
AN:
41576
American (AMR)
AF:
0.00176
AC:
27
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4832
European-Finnish (FIN)
AF:
0.00828
AC:
88
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00557
AC:
379
AN:
68034
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00483
Hom.:
0
Bravo
AF:
0.00314
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00453
AC:
39
ExAC
AF:
0.00492
AC:
597
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00469
EpiControl
AF:
0.00593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:2Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Aug 31, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20981092, 21356581, 27884173, 14718689) -

Sep 25, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GAN: BS1, BS2 -

Giant axonal neuropathy 1 Uncertain:2Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2016
Inherited Neuropathy Consortium Ii, University Of Miami
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 01, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Inherited Neuropathy Consortium
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

GAN-related disorder Benign:1
Apr 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.070
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T;T
Eigen
Benign
-0.12
Eigen_PC
Benign
0.045
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.84
.;T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
0.81
L;L
PhyloP100
6.1
PrimateAI
Pathogenic
0.80
T
Sift4G
Benign
0.27
T;.
Polyphen
0.18
B;B
Vest4
0.73
MVP
0.83
MPC
0.22
ClinPred
0.012
T
GERP RS
5.5
Varity_R
0.38
gMVP
0.49
Mutation Taster
=64/36
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79901179; hg19: chr16-81411091; API